CID 3010955

5-[2-(11-ethyl-5-methyl-6-oxo-dipyrido[[?],[?]][1,4]diazepin-8-yl)ethoxy]-2-methylsulfonyl-3,4-dihydro-1h-isoquinoline-8-carboxylic acid

Structural Information

Molecular Formula
C27H29N5O6S
SMILES
CCN1C2=C(C=CC=N2)N(C(=O)C3=C1N=CC(=C3)CCOC4=C5CCN(CC5=C(C=C4)C(=O)O)S(=O)(=O)C)C
InChI
InChI=1S/C27H29N5O6S/c1-4-32-24-20(26(33)30(2)22-6-5-11-28-25(22)32)14-17(15-29-24)10-13-38-23-8-7-19(27(34)35)21-16-31(39(3,36)37)12-9-18(21)23/h5-8,11,14-15H,4,9-10,12-13,16H2,1-3H3,(H,34,35)
InChIKey
NLXCCDWCDRFIDH-UHFFFAOYSA-N
Compound name
5-[2-(2-ethyl-9-methyl-10-oxo-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-13-yl)ethoxy]-2-methylsulfonyl-3,4-dihydro-1H-isoquinoline-8-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

551.18384 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 552.19112 235.5
[M+Na]+ 574.17306 242.0
[M-H]- 550.17656 237.9
[M+NH4]+ 569.21766 235.9
[M+K]+ 590.14700 241.1
[M+H-H2O]+ 534.18110 224.0
[M+HCOO]- 596.18204 236.4
[M+CH3COO]- 610.19769 239.0
[M+Na-2H]- 572.15851 236.1
[M]+ 551.18329 237.9
[M]- 551.18439 237.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.